Xconomy National

by in

Entry	Author	Date	Location
Bay Area Biotech Startup at Odds with Dana-Farber and Novartis Over Cancer Drug Rights	Ryan McBride	10/28/10	Boston
Agios Adds Alnylam Chief to Board	Ryan McBride	06/24/10	Boston
Genzyme Annual Meeting Remarkably Mundane, Despite Rocky Year	Ryan McBride	06/16/10	Boston
Genzyme Borrows $1B for Stock Buyback	Ryan McBride	06/15/10	Boston
Genzyme Cuts Deal With Carl Icahn on Eve of Shareholder Vote	Ryan McBride	06/09/10	Boston
Genzyme Taps Amgen Vet for Board	Ryan McBride	06/07/10	Boston
Genzyme in “Tough Spot” with Icahn Proxy Challenge—CEO Termeer Courting Key Shareholders	Ryan McBride	05/13/10	Boston
Phase Forward Offering Pharmas One-Stop Shopping for Clinical Research Software	Ryan McBride	03/09/10	Boston
Millipore Taps Langer for Board Seat	Ryan McBride	12/16/09	Boston
Synageva Finishes $45M Round	Ryan McBride	10/20/09	Boston
Another Biogen Director to Retire	Ryan McBride	08/26/09	Boston
Page 1 of 1